Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Is Charles River Laboratories International Inc. (CRL) Going To Burn These Hedge Funds ??

Concerns over rising interest rates and expected further rate increases have hit several stocks hard during the fourth quarter of 2018. Trends reversed 180 degrees during the first half of 2019 amid Powell’s pivot and optimistic expectations towards a trade deal with China. Hedge funds and institutional investors tracked by Insider Monkey usually invest a disproportionate amount of their portfolios in smaller cap stocks. We have been receiving indications that hedge funds were increasing their overall exposure in the second quarter and this is one of the factors behind the recent movements in major indices. In this article, we will take a closer look at hedge fund sentiment towards Charles River Laboratories International Inc. (NYSE:CRL).

Is Charles River Laboratories International Inc. (NYSE:CRL) a worthy investment right now? The best stock pickers are taking a bullish view. The number of bullish hedge fund bets improved by 5 in recent months. Our calculations also showed that CRL isn’t among the 30 most popular stocks among hedge funds (view the video below).
5 Most Popular Stocks Among Hedge Funds
Video: Click the image to watch our video about the top 5 most popular hedge fund stocks.

At the moment there are a large number of indicators stock traders employ to analyze their holdings. Two of the most underrated indicators are hedge fund and insider trading activity. Our researchers have shown that, historically, those who follow the best picks of the top investment managers can outclass the broader indices by a healthy amount (see the details here).

John Rogers Ariel Investments

Unlike some fund managers who are betting on Dow reaching 40000 in a year, our long-short investment strategy doesn’t rely on bull markets to deliver double digit returns. We only rely on hedge fund buy/sell signals. Let’s review the recent hedge fund action regarding Charles River Laboratories International Inc. (NYSE:CRL).

How are hedge funds trading Charles River Laboratories International Inc. (NYSE:CRL)?

Heading into the third quarter of 2019, a total of 29 of the hedge funds tracked by Insider Monkey were long this stock, a change of 21% from the previous quarter. Below, you can check out the change in hedge fund sentiment towards CRL over the last 16 quarters. With the smart money’s sentiment swirling, there exists a select group of notable hedge fund managers who were adding to their holdings considerably (or already accumulated large positions).

CRL_oct2019

According to Insider Monkey’s hedge fund database, Cliff Asness’s AQR Capital Management has the most valuable position in Charles River Laboratories International Inc. (NYSE:CRL), worth close to $317.8 million, comprising 0.4% of its total 13F portfolio. The second largest stake is held by Renaissance Technologies, holding a $236.2 million position; 0.2% of its 13F portfolio is allocated to the stock. Other hedge funds and institutional investors with similar optimism include John W. Rogers’s Ariel Investments, Ken Fisher’s Fisher Asset Management and Israel Englander’s Millennium Management.

With a general bullishness amongst the heavyweights, specific money managers have jumped into Charles River Laboratories International Inc. (NYSE:CRL) headfirst. Healthcor Management LP, managed by Arthur B Cohen and Joseph Healey, initiated the biggest position in Charles River Laboratories International Inc. (NYSE:CRL). Healthcor Management LP had $51.7 million invested in the company at the end of the quarter. Anand Parekh’s Alyeska Investment Group also made a $20.7 million investment in the stock during the quarter. The following funds were also among the new CRL investors: Frederick DiSanto’s Ancora Advisors, Martin D. Sass’s MD Sass, and Alec Litowitz and Ross Laser’s Magnetar Capital.

Let’s go over hedge fund activity in other stocks – not necessarily in the same industry as Charles River Laboratories International Inc. (NYSE:CRL) but similarly valued. These stocks are Robert Half International Inc. (NYSE:RHI), Hexcel Corporation (NYSE:HXL), Sealed Air Corporation (NYSE:SEE), and Five Below Inc (NASDAQ:FIVE). This group of stocks’ market caps are closest to CRL’s market cap.

Ticker No of HFs with positions Total Value of HF Positions (x1000) Change in HF Position
RHI 26 618890 1
HXL 23 150565 -2
SEE 27 1009952 -2
FIVE 38 550414 0
Average 28.5 582455 -0.75

View table here if you experience formatting issues.

As you can see these stocks had an average of 28.5 hedge funds with bullish positions and the average amount invested in these stocks was $582 million. That figure was $1067 million in CRL’s case. Five Below Inc (NASDAQ:FIVE) is the most popular stock in this table. On the other hand Hexcel Corporation (NYSE:HXL) is the least popular one with only 23 bullish hedge fund positions. Charles River Laboratories International Inc. (NYSE:CRL) is not the most popular stock in this group but hedge fund interest is still above average. This is a slightly positive signal but we’d rather spend our time researching stocks that hedge funds are piling on. Our calculations showed that top 20 most popular stocks among hedge funds returned 24.4% in 2019 through September 30th and outperformed the S&P 500 ETF (SPY) by 4 percentage points. Unfortunately CRL wasn’t nearly as popular as these 20 stocks and hedge funds that were betting on CRL were disappointed as the stock returned -6.7% during the third quarter and underperformed the market. If you are interested in investing in large cap stocks with huge upside potential, you should check out the top 20 most popular stocks among hedge funds as many of these stocks already outperformed the market so far this year.

Disclosure: None. This article was originally published at Insider Monkey.

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.